live cricket score india and australia Innovent Biologics Obtains Exclusive Rights to Two Cell Immunotherapy Products in Mainland China, Hong Kong and Macau Novo Nordisk Q1 2020: China grew 13%, ...

Eli Lilly (LLY) emerges among the top performers in Big Pharma in 2024 with obesity drug success, while Novo Nordisk (NVO) ...

As the year comes to a close, the overall level of global mergers and acquisitions activity in 2024 is expected to be $3.5 ...

Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...

INR:3385. members of zerobaseone Innovent Biologics' Phase 3 clinical trial of Sintilimab as first-line treatment for advanced liver cancer reaches primary ...

Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...

Loomis Sayles, an investment management company, released its “International Growth Fund” third quarter 2024 investor letter.

Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.

Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.

Zealand Pharma's GLP-2 drug candidate fails to gain FDA approval due to request for additional trial to confirm efficacy and safety.